Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Reset all filters
01 1BACHEM S.A. Vionnaz CH
Reset all filters
01 1Carbidopa, Process-II
Reset all filters
01 1Switzerland
Reset all filters
01 1Withdrawn by Holder
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Certificate Number : R0-CEP 2020-364 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2021-06-22
Type : Chemical
Substance Number : 755
20
Bachem S.a. Vionnaz Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
One of their significant offerings is Carbidopa, Process-II, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2020-364 - Rev 00
This Chemical Type CEP, issued on June 22, 2021, remains in force until April 22, 2025, ensuring its reliability within the pharmaceutical industry.
Substance Number 755 associated with this CEP further emphasizes